Medicina interna
Specialty
Hospital Sierrallana
Torrelavega, EspañaPublications in collaboration with researchers from Hospital Sierrallana (8)
2023
-
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
2018
-
Human immunodeficiency virus/hepatits C virus coinfection in Spain: Elimination is feasible, but the burden of residual cirrhosis will be significant
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2017
-
Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics
Medicina Clinica, Vol. 149, Núm. 8, pp. 331-338
2016
-
Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics
Open Forum Infectious Diseases, Vol. 3, Núm. 2
2008
-
Characteristics and outcome of AIDS-related hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy
Journal of Acquired Immune Deficiency Syndromes, Vol. 47, Núm. 4, pp. 422-428
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2007
-
Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART
HIV Clinical Trials, Vol. 8, Núm. 5, pp. 328-336